West Pharmaceutical Services Inc (WST)
Industry Medical Instruments & Supplies
This stock can be held in an Investment ISA and an Investment Account
Sell
$316.50
Buy
$317.53
$0.71 (+0.22%)
Prices updated at 04 Jun 2026, 19:07 EDT
| Prices minimum 15 mins delay
Prices in USD
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass ...
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Income statement
Year | 2024 | 2025 |
|---|---|---|
| 2,893m | 3,074m | |
| 999m | 1,104m | |
| 591m | 636m | |
| 20.42 | 20.69 | |
| 493m | 494m | |
| 744m | 773m | |
| Sales, General and administrative | 339m | 394m |
| Interest expenses | 3m | 500,000 |
| Provision for income taxes | 108m | 122m |
| Operating expenses | 408m | 468m |
| Income before taxes | 586m | 601m |
| Net income available to common shareholders | 493m | 494m |
| 6.75 | 6.83 | |
| Net interest income | 17m | 17m |
| Advertising and promotion | - | - |
| Net investment income, net | - | - |
| Realised capital gains (losses), net | - | - |
| Total benefits, claims and expenses | - | - |
| Earnings per share (diluted) | 6.69 | 6.79 |
| Free cash flow per share | 4.3445 | 5.2021 |
| Book value/share | 38.065 | 42.3564 |
| Debt equity ratio | 0.106028 | 0.093955 |
Balance sheet
Year | 2024 | 2025 |
|---|---|---|
| Current assets | 1,538m | 1,978m |
| Current liabilities | 550m | 655m |
| Total capital | 2,885m | 3,379m |
| Total debt | 302m | 321m |
| Total equity | 2,682m | 3,176m |
| Total non current liabilities | - | - |
| Loans | 203m | 203m |
| Total assets | 3,643m | 4,270m |
| Total liabilities | - | - |
| Cash and cash equivalents | 485m | 791m |
| Common stock | 72m | 72m |
Cash flow
Year | 2024 | 2025 |
|---|---|---|
| Cash at beginning of period | 854m | 485m |
| Cash dividends paid | -59m | -61m |
| 276m | 469m | |
| Investments (gains) losses | -379m | -286m |
| 485m | 791m | |
| Net income | - | - |
| 653m | 755m | |
| -377m | -286m |
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.